AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Exploring the Impact of MRD in CLL Treatment
The chapter delves into the considerations surrounding the use of Minimal Residual Disease (MRD) in Chronic Lymphocytic Leukemia (CLL) treatment, discussing the challenges, tools like flow cytometry and NGS, and tailoring testing based on treatment types. It emphasizes the significance of MRD in treatment decisions, citing a UK study focusing on MRD-guided treatments to achieve undetectable MRD levels and deeper disease eradication.